View Older Stories View More Recent Stories
-
Form 485BPOS LAZARD RETIREMENT SERIES
-
Form D/A Lazard MENA Equity Fund
-
Lazard to Announce First Quarter 2024 Financial Results
-
JPMorgan profit beats estimates even as interest income misses predictions
-
Century Therapeutics (IPSC) to Acquire Clade Therapeutics, Announces $60M Private Placement
-
Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics
-
Vertex (VRTX) Enters Into Agreement to Acquire Alpine Immune Sciences (ALPN)
-
Vertex Enters Into Agreement to Acquire Alpine Immune Sciences
-
Inverness Graham Announces Sale of Vista Apex
-
Lazard (LAZ) Reports March 2024 Assets Under Management
-
Lazard Reports March 2024 Assets Under Management
-
Form 497 LAZARD FUNDS INC
-
CMD Global Partners Expands Corporate Advisory Practice in New York and Chicago
-
Form 497 LAZARD FUNDS INC
-
Lazard (LAZ) PT Raised to $52 at JMP Securities, 'a “value play”'
-
Houlihan Lokey (HLI) Continues Expansion of Its Capital Markets Group With Senior Hire
-
Houlihan Lokey Continues Expansion of Its Capital Markets Group With Senior Hire
-
Gain Therapeutics (GANX) Bolsters Management Team with the Appointment of Gene Mack as Chief Financial Officer
-
Gain Therapeutics Bolsters Management Team with the Appointment of Gene Mack as Chief Financial Officer
-
1847 Holdings to Acquire a Commercial Cabinet, Door & Millwork Manufacturer with Revenues of $28.6 Million and $5.2 Million of EBITDA in 2023
-
JPMorgan names CEO Dimon's potential successors including Piepszak, Lake
-
Apollo (APO) -Backed Mobile Internet Company Anuvu Engages Lazard for Asset Sale - WSJ
-
Lambda secures $500 million loan with Nvidia chips as collateral
-
Houlihan Lokey Continues Expansion of Private Funds Advisory Capabilities With Senior Hires for U.S. Primary Practice
-
Lambda Announces $500M GPU-Backed Facility to Expand Cloud for AI
-
Form DEFA14A Lazard, Inc.
-
XOMA Corporation Announces Closing of Tender Offer
-
Oppenheimer (OPY) Appoints William Bird as Director of Equity Research
-
Oppenheimer & Co. Inc. Appoints William Bird Director of Equity Research
-
Kingswood Capital Management Acquires PATCO Products, Formerly Corbion's Caravan Emulsifiers Division
-
David Higley Joins Perella Weinberg as Partner
-
Corbion and Kingswood Capital Management announce the completion of the divestiture of the emulsifier business
-
Labcorp (LH) Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business
-
Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business
-
Global M&A picks up in Q1 after flurry of large deals
-
Form SC 13D/A LAZARD GLOBAL TOTAL RETU Filed by: Saba Capital Management, L.P.
-
1847 Reminds Shareholders to Visit the Company's Website to Receive Schedule K-1 Electronically
-
Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board
-
Juvisé Pharmaceuticals Acquires Multiple Sclerosis Drug PONVORY® (ex-US/Canada) and Opens Its Capital to Bpifrance and Pemberton
-
1847 Holdings Request for Withdrawal of Registration Statement on Form S-3
-
Press release: Orange and MASMOVIL complete transaction to form the leading operator in Spain in terms of customers
-
Géraldine Périchon Appointed Deputy Chief Executive Officer of the Getlink Group
-
Form 24F-2NT LAZARD FUNDS INC For: Dec 31
-
Form 24F-2NT LAZARD RETIREMENT SERIES For: Dec 31
-
Zambia's three-year debt restructuring takes step forward
-
Lazard Global Total Return and Income Fund Declares Monthly Distribution and Issues Estimated Sources of the Distribution Announced in February
-
Form ARS Lazard, Inc. For: Dec 31
-
Form DEFA14A Lazard, Inc.
-
Form DEF 14A Lazard, Inc. For: May 09
-
Petmate Achieves 100% Consensual Reorganization Supported by Significant Capital Investment to Reinvigorate the Business as a Key Partner to its Customers and Suppliers
